Evolution of Endoscopic Bariatric Devices: From Development to Practice

Deepinder Goyal, Vikesh K. Singh, Stuart K Amateau

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVES:To familiarize medical providers with the Food and Drug Administration approval process for antiobesity devices and to provide a brief overview of current and promising endoscopy-based bariatric devices.METHODS:Literature review of published scholarly articles.RESULTS:There has been a rapid development of novel endoscopic bariatric therapies in recent years, resulting in the approval of multiple devices. Several promising endoscopic strategies are currently under investigation and review. The Food and Drug Administration has laid down an objective-tiered model to review antiobesity device applications.DISCUSSION:Endoscopic bariatric devices provide a new and promising paradigm in obesity management both as first-line therapy and as adjunctive treatment to medical and surgical strategies. Physicians who plan to offer endoscopic bariatric therapy in their practice need appropriate understanding of the regulatory processes involved in the development and approval of such devices.

Original languageEnglish (US)
Pages (from-to)679-683
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume114
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Bariatrics
Device Approval
Equipment and Supplies
United States Food and Drug Administration
Therapeutics
Endoscopy
Obesity
Physicians

PubMed: MeSH publication types

  • Journal Article

Cite this

Evolution of Endoscopic Bariatric Devices : From Development to Practice. / Goyal, Deepinder; Singh, Vikesh K.; Amateau, Stuart K.

In: American Journal of Gastroenterology, Vol. 114, No. 4, 01.04.2019, p. 679-683.

Research output: Contribution to journalArticle

@article{9c68309c3c4242f8a2f3fddbc89eb712,
title = "Evolution of Endoscopic Bariatric Devices: From Development to Practice",
abstract = "OBJECTIVES:To familiarize medical providers with the Food and Drug Administration approval process for antiobesity devices and to provide a brief overview of current and promising endoscopy-based bariatric devices.METHODS:Literature review of published scholarly articles.RESULTS:There has been a rapid development of novel endoscopic bariatric therapies in recent years, resulting in the approval of multiple devices. Several promising endoscopic strategies are currently under investigation and review. The Food and Drug Administration has laid down an objective-tiered model to review antiobesity device applications.DISCUSSION:Endoscopic bariatric devices provide a new and promising paradigm in obesity management both as first-line therapy and as adjunctive treatment to medical and surgical strategies. Physicians who plan to offer endoscopic bariatric therapy in their practice need appropriate understanding of the regulatory processes involved in the development and approval of such devices.",
author = "Deepinder Goyal and Singh, {Vikesh K.} and Amateau, {Stuart K}",
year = "2019",
month = "4",
day = "1",
doi = "10.14309/ajg.0000000000000134",
language = "English (US)",
volume = "114",
pages = "679--683",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Evolution of Endoscopic Bariatric Devices

T2 - From Development to Practice

AU - Goyal, Deepinder

AU - Singh, Vikesh K.

AU - Amateau, Stuart K

PY - 2019/4/1

Y1 - 2019/4/1

N2 - OBJECTIVES:To familiarize medical providers with the Food and Drug Administration approval process for antiobesity devices and to provide a brief overview of current and promising endoscopy-based bariatric devices.METHODS:Literature review of published scholarly articles.RESULTS:There has been a rapid development of novel endoscopic bariatric therapies in recent years, resulting in the approval of multiple devices. Several promising endoscopic strategies are currently under investigation and review. The Food and Drug Administration has laid down an objective-tiered model to review antiobesity device applications.DISCUSSION:Endoscopic bariatric devices provide a new and promising paradigm in obesity management both as first-line therapy and as adjunctive treatment to medical and surgical strategies. Physicians who plan to offer endoscopic bariatric therapy in their practice need appropriate understanding of the regulatory processes involved in the development and approval of such devices.

AB - OBJECTIVES:To familiarize medical providers with the Food and Drug Administration approval process for antiobesity devices and to provide a brief overview of current and promising endoscopy-based bariatric devices.METHODS:Literature review of published scholarly articles.RESULTS:There has been a rapid development of novel endoscopic bariatric therapies in recent years, resulting in the approval of multiple devices. Several promising endoscopic strategies are currently under investigation and review. The Food and Drug Administration has laid down an objective-tiered model to review antiobesity device applications.DISCUSSION:Endoscopic bariatric devices provide a new and promising paradigm in obesity management both as first-line therapy and as adjunctive treatment to medical and surgical strategies. Physicians who plan to offer endoscopic bariatric therapy in their practice need appropriate understanding of the regulatory processes involved in the development and approval of such devices.

UR - http://www.scopus.com/inward/record.url?scp=85064316705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064316705&partnerID=8YFLogxK

U2 - 10.14309/ajg.0000000000000134

DO - 10.14309/ajg.0000000000000134

M3 - Article

C2 - 30848732

AN - SCOPUS:85064316705

VL - 114

SP - 679

EP - 683

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 4

ER -